Research Solutions, Inc. (RSSS) stock analysis
Close on Nov 11, 2026Market cap $65.50MP/E 21.6Yield –
StockData Score
Prices as of Nov 11, 2026How the score works
Mixed14 of 30 checks passed
Research Solutions passes 14 of the 30 checks behind our score; 9 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 4/6
- Growth
- 2/6
- Past performance
- 4/6
- Financial health
- 4/6
- Dividend
- 0/6
What stands out
Margin of safety over 20%
The price is 28.7% below fair value, more than the 20% cushion we look for.
Trading below fair value
The share price of $1.94 is below our fair value estimate of $2.72.
Return on capital over 10%
Return on invested capital was 70.1%, above the 10% that usually covers the cost of capital.
No debt
Research Solutions has no borrowings on its latest balance sheet.
What to watch
Return on equity under 15%
Return on equity was 16.3% over the last twelve months and averaged -7.2% over five years; we look for 15% on both.
Revenue growing under 10% a year
Revenue grew 8.6% a year over the last three fiscal years, short of the 10% we look for.
Bankruptcy risk in the grey zone
The Altman Z-score is 2.10; above 3 is the safe zone and below 1.8 the distress zone.
P/B above the industry
Research Solutions's price-to-book of 3.16 is above the Miscellaneous Business Services median of 2.48.
Valuation4/6
P/E against its history
Not enough price and earnings history to compare.
P/E below the industry
Research Solutions's P/E of 21.6 is below the Miscellaneous Business Services median of 25.8.
EV/EBITDA below its 5-year median
Research Solutions's EV/EBITDA of 10.9 is below its 5-year median of 23.9.
P/B above the industry
Research Solutions's price-to-book of 3.16 is above the Miscellaneous Business Services median of 2.48.
Trading below fair value
The share price of $1.94 is below our fair value estimate of $2.72.
Margin of safety over 20%
The price is 28.7% below fair value, more than the 20% cushion we look for.
Growth2/6
Revenue growing under 10% a year
Revenue grew 8.6% a year over the last three fiscal years, short of the 10% we look for.
EPS growing 10%+ a year
Diluted EPS grew 65.1% a year over the last three fiscal years.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing slower than the industry
Revenue grew -1.5% over the last twelve months; the Miscellaneous Business Services median is 9.9%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin improving
Gross margin was 51.9% over the last twelve months, against 49.3% a year earlier.
Past performance4/6
Return on equity under 15%
Return on equity was 16.3% over the last twelve months and averaged -7.2% over five years; we look for 15% on both.
Return on capital over 10%
Return on invested capital was 70.1%, above the 10% that usually covers the cost of capital.
Return on equity above the industry
Research Solutions's return on equity of 16.3% is above the Miscellaneous Business Services median of 6.8%.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin above its 5-year average
Net margin was 5.8% over the last twelve months, against a 5-year average of -0.7%.
Net margin above the industry
Research Solutions's net margin of 5.8% is above the Miscellaneous Business Services median of 3.8%.
Financial health4/6
No debt
Research Solutions has no borrowings on its latest balance sheet.
Debt not rising
With no debt today, leverage cannot have risen.
Debt covered by cash flow
There is no debt to cover.
Interest well covered
No meaningful interest expense to cover.
Short-term assets don't cover short-term debts
Current assets are 0.83 times current liabilities.
Bankruptcy risk in the grey zone
The Altman Z-score is 2.10; above 3 is the safe zone and below 1.8 the distress zone.
Dividend0/6
No dividend
Research Solutions has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itOur estimate per share
$2.72
The share price is 29% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 25.8× | – | 25.8× | $2.32 | 40% |
| EV/EBITDA | 19.8× | 23.9× | 15.7× | $3.21 | 35% |
| P/B | 5.7× | 8.9× | 2.5× | $3.51 | 10% |
| Earnings power | 7.4% cost of equity | – | – | $2.10 | 15% |
| Fair value | $2.72 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Miscellaneous Business Services median 25.8
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
High risk
- Average value traded per day
- $62.22K
- Value traded per 1% price move
- $36.85K
Downside
Medium risk
- Typical loss in a bad month
- 17.7%
- Volatility (annualized)
- 44%
- Sharpe ratio, 1 year
- -0.95
- Beta to the S&P 500 (5Y)
- 0.42
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2012 to 2026
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2026
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -1.5% | +8.6% | +8.8% | +7.2% | |
| Gross profit | +3.6% | +19.5% | +19.5% | +16.1% | |
| Operating income | +43.5% | +146.8% | – | – | |
| Net income | +123.0% | +70.3% | – | – | |
| EPS, diluted | +125.0% | +65.1% | – | – | |
| Free cash flow | -25.3% | +16.2% | +23.1% | +45.1% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2017 | FY2021 | FY2026 | Trend |
|---|---|---|---|---|
| Return on equity | -44.2% | -5.5% | 16.3% | |
| Return on assets | -18.4% | -1.8% | 6.1% | |
| Current ratio | 1.52 | 1.47 | 0.83 | |
| Capex to revenue | 0.2% | 0.1% | 0.1% | |
| Diluted shares | 23M | 26M | 32M |
Where the cash went
Fiscal 2022 to 2026, five years combined
Research Solutions generated $19.65M from operations and spent $1.96M on capital expenditure, dividends and share buybacks. 11% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2026 | 5.8% | 1.05× | 2.65× | 16.3% |
| FY2025 | 2.6% | 1.12× | 3.43× | 9.9% |
| FY2024 | -8.5% | 1.40× | 3.35× | -39.8% |
| FY2023 | 1.5% | 1.94× | 3.18× | 9.4% |
| FY2022 | -5.0% | 1.94× | 3.29× | -31.7% |
| FY2021 | -0.9% | 2.00× | 3.08× | -5.5% |
| FY2020 | -2.1% | 2.46× | 3.20× | -16.8% |
| FY2019 | -3.3% | 2.83× | 3.23× | -30.4% |
| FY2018 | -6.0% | 2.49× | 2.95× | -44.0% |
| FY2017 | -8.9% | 2.07× | 2.40× | -44.2% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2026 against fiscal 2025
- ProfitableNet income above zero$2.82M
- Cash generatingOperating cash flow above zero$5.27M
- Return on assets improvedROA up on the prior year3.0% → 6.1%
- Earnings backed by cashOperating cash flow above net income$5.27M vs $2.82M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose0.78 → 0.83
- No dilutionShare count did not rise32M → 32M
- Gross margin improvedGross margin up on the prior year49.32% → 51.90%
- More efficientAsset turnover rose1.17 → 1.05
See a number that looks wrong?